Meyerhans, Andreas Franz

Personal profile in our Scientific Output Portal (PPC)  

Biography note

University Education

1987 PhD in Chemistry, University of Hamburg, Germany

1982 Diploma in Chemistry, University of Hamburg, Germany

Professional Positions

Since 2010 ICREA Research Professor at the University Pompeu Fabra, Barcelona

1998 - 2009 Full Professor, Saarland University, Germany

1990-1998 Assistant Professor, University of Freiburg, Germany

1988-1990 Postdoctoral Fellow, Institute Pasteur, Paris, France

1987-1988 Postdoctoral Fellow, Institute Biotechnological Research, Braunschweig, Germany

Research lines

 Virus evolution; lymphocyte responses in persistent human infections (HIV, HCV, CMV and Mycobacterium tuberculosis).

Publications

2024 papers

Casella V, Cebollada Rica P, Argilaguet J, Vidal E, González-Cao M, Güerri-Fernandez R, Bocharov G, Meyerhans A. Anti-PD-L1 immunotherapy of chronic virus infection improves virus control without augmenting tissue damage by fibrosis. Viruses 2024; 16(5)

Esteban I, Pastor-Quiñones C, Usero L, Aurrecoechea E, Franceschini L, Esprit A, Gelpí JL, Martínez-Jiménez F, López-Bigas N, Breckpot K, Thielemans K, Leal L, Gómez CE, Sisteré-Oró M, Meyerhans A, Esteban M, Alonso MJ, García F, Plana M. Assessment of human SARS CoV-2-Specific T-Cell responses elicited In Vitro by new computationally designed mRNA immunogens (COVARNA). Vaccines 2024; 12(1): num: 15

Locke M, Grebennikov D, Sazonov I, López-García M, Loguinova M, Meyerhans A, et al. Exploring the therapeutic potential of defective interfering particles in reducing the replication of SARS-CoV-2. Mathematics 2024; 12(12): num: 1904

Marcos-Villar L, Perdiguero B, López-Bravo M, Zamora C, Sin L, Álvarez E, et al. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium. Emerging Microbes & Infections. 2024; 13(1): num: 2387906

Marcos-Villar L, Perdiguero B, Anthiya S, Borrajo ML, Lou G, Franceschini L, Esteban I, Sánchez-Cordón PJ, Zamora C, Sorzano CÓS, Jordá L, Codó L, Gelpí JL, Sisteré-Oró M, Meyerhans A, Thielemans K, Martínez-Jiménez F, López-Vigas N, García F, Alonso MJ, Plana M, Esteban M, Gómez CE. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium. NPJ vaccines. 2024; 9(1): num: 53

Sistere-Oro M.; Du J.; Wortmann D.D.J.; Filippi M.D.; Cañas-Ruano E.; Arrieta-Aldea I.; Marcos-Blanco A.; Castells X.; Grau S.; Garcia-Giralt N.; Perez-Zsolt D.; Boreika R.; Izquierdo-Useros N.; Guerri-Fernandez R.; Meyerhans A. Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination. Journal of Medical Virology 2024; 96(1): num: 29317

2023 papers

Grossman Z.; Meyerhans A.; Bocharov G. An integrative systems biology view of host-pathogen interactions: The regulation of immunity and homeostasis is concomitant, flexible, and smart. Frontiers in Immunology 2023; 13

Casella V, Domenjo-Vila E, Esteve-Codina A, Pedragosa M, Cebollada Rica P, Vidal E, de la Rubia I, López-Rodríguez C, Bocharov G, Argilaguet J, Meyerhans A. Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation. Cell Death and Disease 2023; 14(12): num: 838

Moros A, Cebollada P, et al. Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.. Vaccine 2023; 41(35): 5072-5078

Sergeeva J, Grebennikov D, Casella V, Cebollada-Rica P, Meyerhans A, Bocharov G. Mathematical model predicting the kinetics of intracellular LCMV replication. Mathematics 2023; 11(21)

Barreiro A, Prenafeta A, Bech-Sabat G, Roca M, Perozo Mur E, March R, Gonzalez-Gonzalez L, Madrenas L, Corominas J, Fernandez A, Moros A, Cañete M, Molas M, Pentinat-Pelegrin T, Panosa C, Moreno A, Puigvert Molas E, Pol Vilarrassa E, Palmada J, Garriga C, Prat Cabañas T, Iglesias-Fernandez J, Vergara-Alert J, Lorca-Oro C, Roca N, Fernandez-Bastit L, Rodon J, Perez M, Segales J, Pradenas E, Marfil S, Trinite B, Ortiz R, Clotet B, Blanco J, Diaz Pedroza J, Ampudia Carrasco R, Rosales Salgado Y, Loubat-Casanovas J, Capdevila Larripa S, Prado JG, Barretina J, Sistere-Oro M, Cebollada Rica P, Meyerhans A, Ferrer L. Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2. iScience 2023; 26(3)

Prenafeta A, Bech-Sàbat G, Moros A, Barreiro A, Fernández A, Cañete M, et al. Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates. iScience 2023; 26(7)

Kobayashi-Ishihara M, Frazão Smutná K, Alonso FE, Argilaguet J, Esteve-Codina A, Geiger K et al. Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells. Communications Biology 2023; 6(1)

Duran-Castells C, Llano A, Kawana-Tachikawa A, Prats A, Martinez-Zalacain I, Kobayashi-Ishihara M, Oriol-Tordera B, Peña R, Galvez C, Silva-Arrieta S, Clotet B, Riveira-Muñoz E, Ballana E, Prado JG, Martinez-Picado J, Sanchez J, Mothe B, Hartigan-O¿connor D, Wyss-Coray T, Meyerhans A, Gisslen M, Price RW, Soriano-Mas C, Muñoz-Moreno JA, Brander C, Ruiz-Riol M. Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction. Journal of Virology 2023; 97(2)

Sazonov I, Grebennikov D, Savinkov R, Soboleva A, Pavlishin K, Meyerhans A, Bocharov G. Stochastic Modelling of HIV-1 Replication in a CD4 T Cell with an IFN Response. Viruses 2023; 15(2)

Domenjo-Vila E, Casella V, Iwabuchi R, Fossum E, Pedragosa M, Castellvi Q, Cebollada Rica P, Kaisho T, Terahara K, Bocharov G, Argilaguet J, Meyerhans A. XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections. Cell Reports 2023; 42(2)

2022 papers

Sisteré-Oró M, Andrade N, Wortmann DDJ, Du J, Garcia-Giralt N, González-Cao M, Güerri-Fernández R, Meyerhans A. Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination. Frontiers in Immunology 2022; 13

Sisteré-Oró M, Wortmann DDJ, Andrade N, Aguilar A, Mayo de Las Casas C, Casabal FG, Torres S, Bona Salinas E, Raventos Soler L, Arcas A, Esparre C, Garcia B, Valarezo J, Rosell R, Güerri-Fernandez R, Gonzalez-Cao M, Meyerhans A. Brief research report: Anti-SARS-CoV-2 immunity in long lasting responders to cancer immunotherapy through mRNA-based COVID-19 vaccination. Frontiers in Immunology 2022; 13

Bocharov G, Grebennikov D, Cebollada Rica P, Domenjo-Vila E, Casella V, Meyerhans A. Functional cure of a chronic virus infection by shifting the virus - host equilibrium state. Frontiers in Immunology 2022; 13

Grebennikov D, Karsonova A, Loguinova M, Casella V, Mayerhans A, Bocharov G. Predicting the kinetic coordination of immune response dynamics in SARS-CoV-2 infection: implications for disease pathogenesis. Mathematics 2022; 10(17)

Sazonov I, Grebennikov D, Meyerhans A, Bocharov G. Sensitivity of SARS-CoV-2 life cycle to IFN effects and ACE2 binding unveiled with a stochastic model. Viruses 2022; 14(2)

2021 papers

Bocharov G, Grebennikov D, Argilaguet J, Meyerhans A. Examining the cooperativity mode of antibody and CD8 + T cell immune responses for vaccinology. Trends in immunology. 2021; 42(10): 852-855

Bessonov N, Bocharov G, Meyerhans A, Popov V, Volper V. Existence and dynamics of strains in a nonlocal reaction-diffusion model of viral evolution. SIAM Journal on Applied Mathematics 2021; 81(1): 107-28

Grebennikov D, Kholodareva E, Sazonov I, Karsonova A, Meyerhans A, Bocharov G. Intracellular life cycle kinetics of SARS-CoV-2 predicted using mathematical modelling. Viruses 2021; 13(9)

Sazonov I, Grebennikov D, Meyerhans A, Bocharov G. Markov chain-based stochastic modelling of HIV-1 life cycle in a CD4 T cell. Mathematics 2021; 9(17)

Lyonnais S, Sadiq SK, Lorca-Oró C, Dufau L, Nieto-Marquez S, Escribà T, Gabrielli N, Tan X, Ouizougun-Oubari M, Okoronkwo J, Reboud-Ravaux M, Gatell JM, Marquet R, Paillart JC, Meyerhans A, Tisné C, Gorelick RJ, Mirambeau G. The HIV-1 nucleocapsid regulates its own condensation by phase-separated activity-enhancing sequestration of the viral protease during maturation. Viruses 2021; 13(11)

2020 papers

Gonzalez-Cao M, Morán T, Dalmau J, Garcia-Corbacho J, Bracht JWP, Bernabe R et al. Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: The phase 2 DURVAST study. JAMA oncology. 2020; 6(7): 1063-7

García de Abajo FJ, Hernández RJ, Kaminer I, Meyerhans A, Rosell-Llompart J, Sanchez-Elsner T. Back to normal: an old physics route to reduce SARS-CoV-2 transmission in indoor spaces. ACS Nano. 2020; 14(7): 7704-13

Bocharov G, Volpert V, Ludewig B, Meyerhans A. Editorial: mathematical modeling of the immune system in homeostasis, infection and disease. Frontiers in Immunology 2020; 10

Gomara MJ, Perez Y, Gomez-Gutierrez P, Herrera C, Ziprin P, Martinez JP, Meyerhans A, Perez JJ, Haro I. Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide. Scientific Reports 2020; 10(1)

Prochnow H, Rox K, Birudukota NVS, Weichert L, Hotop SK, Klahn P et al. Labyrinthopeptins exert broad-spectrum antiviral activity through lipid-binding-mediated virolysis. Journal of Virology 2020; 94(2): 1-24

Shcherbatova O, Grebennikov D, Sazonov I, Meyerhans A, Bocharov G. Modeling of the HIV-1 life cycle in productively infected cells to predict novel therapeutic targets. Pathogens 2020; 9(4)

Bessonov N, Bocharov G, Meyerhans A, Popov V, Volpert V. Nonlocal reaction-diffusion model of viral evolution: emergence of virus strains. Mathematics 2020; 8(1)

Bocharov G, Casella V, Argilaguet J, Grebennikov D, Güerri-Fernandez R, Ludewig B, Meyerhans A. Numbers game and immune geography as determinants of coronavirus pathogenicity. Frontiers in Cellular and Infection Microbiology 2020; 10

Huerga Encabo H, Traveset L, Argilaguet J, Angulo A, Nistal-Villán E, Jaiswal R, Escalante CR, Gekas C, Meyerhans A, Aramburu J, López-Rodríguez C. The transcription factor NFAT5 limits infection-induced type I interferon responses. Journal of Experimental Medicine 2020; 217(3)

Sazonov I, Grebennikov D, Kelbert M, Meyerhans A, Bocharov G. Viral infection dynamics model based on a Markov process with time delay between cell infection and progeny production. Mathematics 2020; 8(8)

2019 papers

Gonzalez-Cao M, Martinez-Picado J, Karachaliou N, Rosell R, Meyerhans A. Cancer immunotherapy of patients with HIV infection.. Clinical and Translational Oncology 2019; 21(6): 713-720

Pedragosa M, Riera G, Casella V, Esteve-Codina A, Steuerman Y, Seth C, Bocharov G, Heath S, Gat-Viks I, Argilaguet J, Meyerhans A. Linking cell dynamics with gene coexpression networks to characterize key events in chronic virus infections. Frontiers in Immunology 2019; 10(1002)

Grebennikov DS, Donets DO, Orlova OG, Argilaguet J, Meyerhans A, Bocharov GA. Mathematical modeling of the intracellular regulation of immune processes. Molecular Biology. 2019; 53(5): 718-731

Gomara MJ, Perez Y, Martinez JP, Barnadas-Rodriguez R, Schultz A, von Briesen H, Peralvarez-Marin A, Meyerhans A, Haro I. Peptide assembly on the membrane determines the HIV-1 inhibitory activity of dual-targeting fusion inhibitor peptides. Scientific Reports 2019; 9(1)

Zheltkova V, Argilaguet J, Peligero C, Bocharov G, Meyerhans A. Prediction of PD-L1 inhibition effects for HIV-infected individuals. PLOS Computational Biology 2019; 15(11)

Grebennikov D, Bouchnita A, Volpert V, Bessonov N, Meyerhans A, Bocharov G. Spatial lymphocyte dynamics in lymph nodes predicts the cytotoxic T cell frequency needed for HIV infection control. Frontiers in Immunology 2019; 10

Argilaguet J, Pedragosa M, Esteve-Codina A, Riera G, Vidal E, Peligero-Cruz C, Casella V, Andreu D, Kaisho T, Bocharov G, Ludewig B, Heath S, Meyerhans A. Systems analysis reveals complex biological processes during virus infection fate decisions. Genome Research 2019; 29(6): 907-919

2018 papers

Gonzalez-Cao M, Karachaliou N, Santarpia M, Viteri S, Meyerhans A, Rosell R. Activation of viral defense signaling in cancer.. Therapeutic Advances in Medical Oncology. 2018; 10: 1-12

Olvera A, Martinez JP, Casadellà M, Llano A, Rosás M, Mothe B, Ruiz-Riol M, Arsequell G, Valencia G, Noguera-Julian M, Paredes R, Meyerhans A, Brander C. Benzyl-2-acetamido-2-deoxy-a-d-galactopyranoside increases human immunodeficiency virus replication and viral outgrowth efficacy in vitro. Frontiers in Immunology 2018; 8

Sadiq SK, Mirambeau G, Meyerhans A. Equilibrium Model of Drug-Modulated GagPol-Embedded HIV-1 Reverse Transcriptase Dimerization to Enhance Premature Protease Activation.. AIDS Research and Human Retroviruses 2018; 34(9): 804-807

Kobayashi-Ishihara M, Terahara K, Martinez JP, Yamagishi M, Iwabuchi R, Brander C, Ato M, Watanabe T, Meyerhans A, Tsunetsugu-Yokota Ya. HIV LTR-driven antisense RNA by itself has regulatory function and may curtail virus reactivation from latency. Frontiers in Microbiology 2018; 9

Bocharov G, Meyerhans A, Bessonov N, Trofimchuk S, Volpert V. Interplay between reaction and diffusion processes in governing the dynamics of virus infections. Journal of Theoretical Biology 2018; 457: 221-236

2017 papers

Bocharov G, Meyerhans A, Bessonov N, Trofimchuk S, Volpert V. Modelling the dynamics of virus infection and immune response in space and time. International Journal of Parallel, Emergent and Distributed Systems. 2017; 34(4): 341-355

Koutsoudakis G, Paris de León A, Herrera C, Dorner M, Pérez-Vilaró G, Lyonnais S, Grijalvo S, Eritja R, Meyerhans A, Mirambeau G, Díez J. Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo. Antimicrobial Agents and Chemotherapy 2017; 61(5): 02354-16

Chen H-C, Martinez JP, Zorita E, Meyerhans A, Filion GJ. Position effects influence HIV latency reversal. Nature Structural and Molecular Biology 2017; 24(1): 47-54

Fleta Soriano, Eric; Smutna, Katarína ; Martinez, Javier P ; Lorca Oró, Cristina ; Sadiq, Kashif ; Mirambeau, Gilles ; Lopez-Iglesias, Carmen ; Bosch, Marta ; Pol, Albert ; Brönstrup, Mark ; Díez Antón, Juana ; Meyerhans, Andreas. The myxobacterial metabolite soraphen A inhibits HIV-1 by reducing virus production and altering virion composition. Antimicrobial Agents and Chemotherapy 2017; 61(8)

Neubauer JC, Sébastien I, Germann A, Müller A, Meyerhans A, von Briesen H, Zimmermann H. Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells. Cytotechnology International journal of cell culture and biotechnology. 2017; 69(1): 57-73

Chen HC, Martinez JP, Zorita E, Meyerhans A, Filion GJ. Position effects influence HIV latency reversal.Nature Structural & Molecular Biology 24(1):47-54 (2017). doi: 10.1038/nsmb.3328. (commented in: CiuffiA, Cristinelli S, Rato S. Single-virus tracking uncovers the missing link between HIV integration site location and viral gene expression. Nat Struct Mol Biol. 2017 Jan 5;24(1):8-11. doi: 10.1038/nsmb.3358. )

Anass Bouchnita, Gennady Bocharov, Andreas Meyerhans, and Vitaly Volpert. Towards a Multiscale Model of Acute HIV Infection. Computation 2017 5, 6; doi:10.3390/computation5010006.

Anass Bouchnita, Gennady Bocharov, Andreas Meyerhans, and Vitaly Volpert. Hybrid approach to model the spatial regulation of T cell responses. BMC Immunology Journal ( accepted).

2016 papers

Bocharov G, Meyerhans A, Bessonov N, Trofimchuk S, Volpert V. Spatiotemporal Dynamics of Virus Infection Spreading in Tissues. PLoS One. Dec 20;11(12):e0168576 (2016). doi: 10.1371/journal.pone.0168576.

Chen HC, Martinez JP, Zorita E, Meyerhans A, Filion GJ. Position effects influence HIV latency reversal. Nature Structural & Molecular Biology; published online 21 November 2016; doi:10.1038/nsmb.3328

Tsunetsugu-Yokota Y, Kobayahi-Ishihara M, Wada Y, Terahara K, Takeyama H, Kawana-Tachikawa A, Tokunaga K, Yamagishi M, Martinez JP, Meyerhans A. Homeostatically maintained resting naive CD4+ T cells resist latent HIV reactivation. Frontiers in Micobiology 7:1944 (2016).

Neubauer JC, Sébastien I, Germann A, Müller SC, Meyerhans A, von Briesen H, Zimmermann H. Towards Standardized Automated Immunomonitoring: an Automated ELISpot Assay for Safe and Parallelized Functionality Analysis of Immune Cells. Cytotechnology Nov 28. [Epub ahead of print] (2016).

Brai A, Fazi R, Tintori C, Zamperini C, Bugli F, Sanguinetti M, Stigliano E, Esté J, Badia R, Franco S, Martinez MA, Martinez JP, Meyerhans A, Saladini F, Zazzi M, Garbelli A, Maga G, Botta M. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proc Natl Acad Sci U S A. May 10;113(19):5388-93 (2016). doi: 10.1073/pnas.1522987113.

Carreras-Sureda A, Rubio-Moscardo F, Olvera A, Argilaguet J, Kiefer K, Mothe B, Meyerhans A, Brander C, Vicente R. Lymphocyte activation dynamics is shaped by hereditary components at chromosome region 17q12-q21. PlosOne 11(11):e0166414 (2016). doi: 10.1371/journal.pone.0166414.

Sanchez-Merino V, Fabra-Garcia A, Gonzalez N, Nicolas D, Merino-Mansilla A, Manzardo C, Ambrosioni J, Schultz A, Meyerhans A, Mascola JR, Gatell JM, Alcami J, Miro JM, Yuste E. Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection. J Virol. May 12;90(11):5231-45 (2016). doi: 10.1128/JVI.00049-16.

Latorre I, Esteve-Sole A, Redondo D, Giest S, Argilaguet J, Alvarez S, Peligero C, Forstmann I, Crespo M, Pascual J, Meyerhans A. Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients. Transpl Immunol. Mar;35:1-6 (2016). doi: 10.1016/j.trim.2016.01.004.

2015 papers

Latorre I, Leidinger P, Backes C, Domínguez J, de Souza-Galvão ML, Maldonado J, Prat C, Ruiz-Manzano J, Sánchez F, Casas I, Keller A, von Briesen H, Knobel H, Meese E, Meyerhans A. A novel whole blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis. European Respiratory Journal 45, 1173-1176 (2015).

Berger CT, Llano A, JM, Brumme ZL, Brockman MA, Cedeño S, Harrigan PR, Kaufmann DE, Heckerman D,Meyerhans A, Brander C. Immune screening identifies novel protein products encoded in anti-sense reading frames of HIV-1. Journal Virology 89, 4015-4019 (2015).

Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran F, Kalesse M, Harmrolfs K, Müller R, Martinez J, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J. Soraphen A: a broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity. Journal of Hepatology 63(4):813-21 (2015).

Martinez JP, Sasse F, Brönstrup M, Diez J, Meyerhans A. Antiviral drug discovery: broad-spectrum drugs from nature. Nat. Prod. Rep., 32 (1), 29 - 48 (2015)

Bocharov G, Argilaguet J, Meyerhans A. Understanding Experimental LCMV Infection of Mice: The Role of Mathematical Models. J Immunol Res. 2015:739706 (2015).

Piron M, Plasencia A, Fleta-Soriano E, Martinez A, Martinez JP, Torner N, Sauleda S, Meyerhans A, Escalé J, Trilla A, Pumarola T, Martinez MJ. Low Seroprevalence of West Nile Virus in Blood Donors from Catalonia, Spain. Vector Borne Zoonotic Dis. 15(12):782-4 (2015).

Peligero C, Argilaguet J, Güerri-Fernandez R, Torres B, Ligero C, Colomer P, Plana M, Knobel H, García F,Meyerhans A. PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia. PLoS Pathog. 11(12):e1005270 (2015).

Elsebai MF, Koutsoudakis G, Saludes V, Pérez-Vilaró G, Turpeinen A, Mattila S, Pirttilä AM, Fontaine-Vive F, Mehiri M, Meyerhans A, Diez J. Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke. J Virol. 90(4):1918-30 (2015).

RM Tretyakova, A Meyerhans, GA Bocharov. A drug pharmacodynamics and pharmacokinetics based approach towards stabilization of HIV infection dynamics. Russian Journal of Numerical Analysis and Mathematical Modelling 30 (5), 299-310 (2015).

GA Bocharov, IS Telatnikov, VA Chereshnev, J Martinez, A Meyerhans. Mathematical modelling of the within-host HIV quasispecies dynamics in response to antiviral treatment. Russian Journal of Numerical Analysis and Mathematical Modelling 30 (3), 157-170 (2015).

HT Banks, DF Kapraun, KG Link, WC Thompson, C Peligero, J Argilaguet, A. Meyerhans. Analysis of variability in estimates of cell proliferation parameters for cyton-based models using CFSE-based flow cytometry data. Journal of Inverse and Ill-posed Problems 23 (2), 135-171 (2015).

HT Banks, DF Kapraun, C Peligero, J Argilaguet, A Meyerhans. Evaluating the importance of mitotic asymmetry in cyton-based models for CFSE-based flow cytometry data. Int. J. Pure Appl. Math 100, 131-156 (2015).